Extemporaneous compounding for the drugs that may be used in COVID-19 treatment

Jhohann Richard de Lima Benzi Departamento de Análises Clínicas, Toxicológicas e Bromatológicas da Faculdade de Ciências Farmacêuticas de Ribeirão Preto Campus Universitário da USP - Ribeirão Preto - SP, Brasil https://orcid.org/0000-0001-6986-6193

Keywords: COVID-19, chloroquine, hydroxychloroquine, ivermectin, extemporaneous compounding

None

Published

2020-04-15

Issue

Section

Letter to the Editor